Humana Updates Medicare Advantage Coverage for AngioDynamics NanoKnife
Humana updated its Medicare Advantage coverage policy supporting broader access to AngioDynamics’ NanoKnife irreversible electroporation treatment for prostate and liver cancer.
Humana updated its Medicare Advantage coverage policy supporting broader access to AngioDynamics’ NanoKnife irreversible electroporation treatment for prostate and liver cancer.